Legacy Capital Partners Cut International Business Machs Com (IBM) Stake By $1.26 Million; Last Week Paratek Pharmaceuticals (PRTK) Analysts

October 23, 2017 - By Ellis Scott

Among 9 analysts covering Paratek Pharmaceuticals (NASDAQ:PRTK), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Paratek Pharmaceuticals had 21 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was initiated by Gabelli with “Buy” on Thursday, July 23. Leerink Swann maintained the stock with “Buy” rating in Thursday, June 15 report. The company was upgraded on Wednesday, September 2 by Zacks. The stock has “Buy” rating by H.C. Wainwright on Friday, June 17. Zacks downgraded the shares of PRTK in report on Saturday, August 8 to “Hold” rating. Robert W. Baird initiated it with “Outperform” rating and $30 target in Friday, May 13 report. Leerink Swann reinitiated the shares of PRTK in report on Thursday, October 27 with “Outperform” rating. Wedbush maintained it with “Outperform” rating and $34 target in Tuesday, April 4 report. On Monday, June 5 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The rating was maintained by Ladenburg Thalmann with “Buy” on Friday, June 17. See Paratek Pharmaceuticals Inc (NASDAQ:PRTK) latest ratings:

21/09/2017 Broker: Robert W. Baird Rating: Buy New Target: $40.0 Maintain
23/08/2017 Broker: Cantor Fitzgerald Rating: Buy Maintain
18/07/2017 Broker: Leerink Swann Rating: Buy New Target: $37.0000 Maintain
18/07/2017 Broker: H.C. Wainwright Rating: Buy New Target: $43.0000 Maintain
17/07/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $50.0000 Maintain
29/06/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $50.0000 Maintain
21/06/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $50.0000 Maintain
15/06/2017 Broker: Leerink Swann Rating: Buy New Target: $37.0000 Maintain
05/06/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $33.0000 Maintain
19/05/2017 Broker: Raymond James Rating: Strong Buy New Target: $36.00 Initiates Coverage On




Legacy Capital Partners Inc decreased International Business Machs Com (IBM) stake by 71.07% reported in 2017Q2 SEC filing. Legacy Capital Partners Inc sold 8,209 shares as International Business Machs Com (IBM)’s stock declined 15.88%. The Legacy Capital Partners Inc holds 3,341 shares with $514,000 value, down from 11,550 last quarter. International Business Machs Com now has $148.69 billion valuation. The stock decreased 1.55% or $2.52 during the last trading session, reaching $159.55. About 5.78M shares traded or 17.48% up from the average. International Business Machines Corp. (NYSE:IBM) has risen 4.86% since October 23, 2016 and is uptrending. It has underperformed by 11.84% the S&P500.

Since May 16, 2017, it had 1 buying transaction, and 0 insider sales for $263,180 activity. Shares for $263,180 were bought by OWENS JAMES W on Tuesday, May 16.

Among 29 analysts covering International Business Machines (NYSE:IBM), 8 have Buy rating, 5 Sell and 16 Hold. Therefore 28% are positive. International Business Machines had 107 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of International Business Machines Corp. (NYSE:IBM) earned “Hold” rating by Cantor Fitzgerald on Tuesday, April 19. As per Wednesday, July 19, the company rating was upgraded by Standpoint Research. BMO Capital Markets maintained it with “Market Perform” rating and $165 target in Tuesday, July 19 report. The firm has “Sell” rating given on Wednesday, July 12 by Jefferies. RBC Capital Markets maintained International Business Machines Corp. (NYSE:IBM) rating on Tuesday, October 20. RBC Capital Markets has “Sector Perform” rating and $150.0 target. As per Tuesday, October 20, the company rating was maintained by Deutsche Bank. RBC Capital Markets maintained the shares of IBM in report on Thursday, October 12 with “Hold” rating. The stock of International Business Machines Corp. (NYSE:IBM) has “Hold” rating given on Tuesday, June 27 by BMO Capital Markets. RBC Capital Markets maintained International Business Machines Corp. (NYSE:IBM) on Thursday, August 31 with “Hold” rating. As per Wednesday, October 21, the company rating was maintained by Citigroup.

Investors sentiment decreased to 0.72 in Q2 2017. Its down 0.25, from 0.97 in 2017Q1. It dived, as 100 investors sold IBM shares while 695 reduced holdings. 91 funds opened positions while 484 raised stakes. 530.91 million shares or 0.81% less from 535.24 million shares in 2017Q1 were reported. Renaissance Technologies Limited Liability Company invested 0.53% in International Business Machines Corp. (NYSE:IBM). Burns J W Ny has invested 0.25% in International Business Machines Corp. (NYSE:IBM). 407,724 are owned by Commonwealth Equity Service. Berkshire Asset Lc Pa has invested 0.35% in International Business Machines Corp. (NYSE:IBM). Sun Life Financial stated it has 9,396 shares or 0.15% of all its holdings. 29,418 are owned by Sumitomo Life Insurance Company. The Quebec – Canada-based Sector Pension Investment Board has invested 0.13% in International Business Machines Corp. (NYSE:IBM). Martin And Inc Tn owns 12,650 shares or 0.6% of their US portfolio. Nippon Life Insur Company stated it has 28,183 shares or 0.08% of all its holdings. Trust Investment holds 1.18% or 7,110 shares in its portfolio. Pittenger And Anderson Inc stated it has 0.01% of its portfolio in International Business Machines Corp. (NYSE:IBM). Moreover, Tdam Usa Inc has 0.52% invested in International Business Machines Corp. (NYSE:IBM) for 66,050 shares. Aimz Ltd Co holds 3% of its portfolio in International Business Machines Corp. (NYSE:IBM) for 23,164 shares. Choate Invest Advsr invested 0% in International Business Machines Corp. (NYSE:IBM). Salem Counselors Incorporated accumulated 29,928 shares.

The stock decreased 3.66% or $0.85 during the last trading session, reaching $22.35. About 186,674 shares traded. Paratek Pharmaceuticals Inc (NASDAQ:PRTK) has risen 62.03% since October 23, 2016 and is uptrending. It has outperformed by 45.33% the S&P500.

Investors sentiment decreased to 1.89 in Q2 2017. Its down 0.15, from 2.04 in 2017Q1. It worsened, as 13 investors sold Paratek Pharmaceuticals Inc shares while 23 reduced holdings. 28 funds opened positions while 40 raised stakes. 19.26 million shares or 15.88% more from 16.62 million shares in 2017Q1 were reported. Essex Invest Management Co Ltd Liability Com reported 0.13% in Paratek Pharmaceuticals Inc (NASDAQ:PRTK). Ardsley Advisory Prtn accumulated 11,000 shares. Driehaus Capital Lc invested in 137,228 shares. Next Grp holds 73 shares. Alliancebernstein L P holds 20,900 shares or 0% of its portfolio. C World Gru Hldg A S reported 439,400 shares or 0.16% of all its holdings. Victory accumulated 32,290 shares or 0% of the stock. Pnc Financial Grp stated it has 0% of its portfolio in Paratek Pharmaceuticals Inc (NASDAQ:PRTK). Granahan Invest Ma accumulated 51,238 shares or 0.11% of the stock. Jpmorgan Chase And reported 199,725 shares. 257,748 were reported by Roumell Asset Mgmt Llc. Baupost Group Limited Liability Company Ma owns 2.39 million shares. Citigroup holds 0% of its portfolio in Paratek Pharmaceuticals Inc (NASDAQ:PRTK) for 7,828 shares. Swiss Natl Bank owns 30,100 shares. Ameriprise has invested 0% in Paratek Pharmaceuticals Inc (NASDAQ:PRTK).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.